These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 15520856)
1. Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population? Pajukanta P J Clin Invest; 2004 Nov; 114(9):1244-7. PubMed ID: 15520856 [TBL] [Abstract][Full Text] [Related]
2. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Wang J; Burnett JR; Near S; Young K; Zinman B; Hanley AJ; Connelly PW; Harris SB; Hegele RA Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1983-9. PubMed ID: 10938021 [TBL] [Abstract][Full Text] [Related]
3. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. Frikke-Schmidt R; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A J Clin Invest; 2004 Nov; 114(9):1343-53. PubMed ID: 15520867 [TBL] [Abstract][Full Text] [Related]
4. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Brunham LR; Singaraja RR; Hayden MR Annu Rev Nutr; 2006; 26():105-29. PubMed ID: 16704350 [TBL] [Abstract][Full Text] [Related]
5. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556 [TBL] [Abstract][Full Text] [Related]
6. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia. Hovingh GK; Van Wijland MJ; Brownlie A; Bisoendial RJ; Hayden MR; Kastelein JJ; Groen AK J Lipid Res; 2003 Jun; 44(6):1251-5. PubMed ID: 12700344 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol. Candini C; Schimmel AW; Peter J; Bochem AE; Holleboom AG; Vergeer M; Dullaart RP; Dallinga-Thie GM; Hovingh GK; Khoo KL; Fasano T; Bocchi L; Calandra S; Kuivenhoven JA; Motazacker MM Atherosclerosis; 2010 Dec; 213(2):492-8. PubMed ID: 20880529 [TBL] [Abstract][Full Text] [Related]
8. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C. Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707 [TBL] [Abstract][Full Text] [Related]
9. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations. Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475 [TBL] [Abstract][Full Text] [Related]
10. Screening for functional sequence variations and mutations in ABCA1. Probst MC; Thumann H; Aslanidis C; Langmann T; Buechler C; Patsch W; Baralle FE; Dallinga-Thie GM; Geisel J; Keller C; Menys VC; Schmitz G Atherosclerosis; 2004 Aug; 175(2):269-79. PubMed ID: 15262183 [TBL] [Abstract][Full Text] [Related]
11. Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants. Quazi F; Molday RS J Biol Chem; 2013 Nov; 288(48):34414-26. PubMed ID: 24097981 [TBL] [Abstract][Full Text] [Related]
12. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. Clee SM; Kastelein JJ; van Dam M; Marcil M; Roomp K; Zwarts KY; Collins JA; Roelants R; Tamasawa N; Stulc T; Suda T; Ceska R; Boucher B; Rondeau C; DeSouich C; Brooks-Wilson A; Molhuizen HO; Frohlich J; Genest J; Hayden MR J Clin Invest; 2000 Nov; 106(10):1263-70. PubMed ID: 11086027 [TBL] [Abstract][Full Text] [Related]
13. A case of Tangier disease with a novel mutation in the C-terminal region of ATP-binding cassette transporter A1. Guan JZ; Tamasawa N; Brunham LR; Matsui J; Murakami H; Suda T; Ochiai S; Tsutsui M; Kudou K; Satoh K; Hayden MR Am J Med Genet A; 2004 Nov; 130A(4):398-401. PubMed ID: 15384103 [TBL] [Abstract][Full Text] [Related]
14. Tangier disease: epidemiology, pathophysiology, and management. Puntoni M; Sbrana F; Bigazzi F; Sampietro T Am J Cardiovasc Drugs; 2012 Oct; 12(5):303-11. PubMed ID: 22913675 [TBL] [Abstract][Full Text] [Related]
15. Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1. Oram JF Trends Mol Med; 2002 Apr; 8(4):168-73. PubMed ID: 11927274 [TBL] [Abstract][Full Text] [Related]
16. Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia. Slatter TL; Williams MJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Morison IM; McCormick SP Atherosclerosis; 2006 Aug; 187(2):393-400. PubMed ID: 16225879 [TBL] [Abstract][Full Text] [Related]
17. Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype. Mantaring M; Rhyne J; Ho Hong S; Miller M Transl Res; 2007 Apr; 149(4):205-10. PubMed ID: 17383594 [TBL] [Abstract][Full Text] [Related]
18. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Oram JF; Vaughan AM Curr Opin Lipidol; 2000 Jun; 11(3):253-60. PubMed ID: 10882340 [TBL] [Abstract][Full Text] [Related]
19. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency. Marcil M; Bissonnette R; Vincent J; Krimbou L; Genest J Circulation; 2003 Mar; 107(10):1366-71. PubMed ID: 12642355 [TBL] [Abstract][Full Text] [Related]